Nadine Kaskas, MD
Dermatology · New York, NYNPI 1275929572
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,500 of the $1,762 with a category attached, or 85.2%. EPI Health, LLC accounts for 85.2% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $1,544 and has fallen 98.8% since, to $18 in 2025. That places this record below the midpoint for dermatology clinicians in NY, where the typical reported total is $2,360.
Across 9 payments — averaging $195.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EPI Health, LLC$2K
- Amgen$124
- AbbVie$119
- Arcutis Biotherapeutics, Inc.$18
Across 7 payments — averaging $35,662 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- UCB SA$250K
What the payments were for
- Consulting fees$1,50085%
- Food & beverage$26215%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EPI Health, LLC | 1 | $1,500 |
| Amgen | 1 | $124 |
| AbbVie | 6 | $119 |
| Arcutis Biotherapeutics, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,762 in reported general payments places this provider in the 45th percentile of 1,151 dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 34 | $693 |
| Clobetasol Propionate | 13 | $483 |
| Mometasone Furoate | 15 | $249 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New York
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Joshua ZeichnerNew York$2.1M
- Emma GuttmanNew York$1.7M
- George HanNew York$1.6M
- Amy SpizuocoNew York$1.3M
- Andrew AlexisNew York$834K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.